awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q22305863-68644C32-6127-4164-98FD-32250C5B1F2A
Q22305863-68644C32-6127-4164-98FD-32250C5B1F2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22305863-68644C32-6127-4164-98FD-32250C5B1F2A
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
P2860
Q22305863-68644C32-6127-4164-98FD-32250C5B1F2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22305863-68644C32-6127-4164-98FD-32250C5B1F2A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f4ad70c6c6f5fef1019355257e1201a08c0a53e
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.